Fig. 3From: Integrated analyses of microRNA-29 family and the related combination biomarkers demonstrate their widespread influence on risk, recurrence, metastasis and survival outcome in colorectal cancerThe SROC curves in the diagnosis of CRC. a SROC curve overall including the outliers for miR-29; b SROC curve of outliers excluded for miR-29; c SROC curve for miR-29 in serum samples; d SROC curve for miR-29 in plasma samples; e SROC curve for miR-29 in circulating samples; f SROC curve for combination markers based on miR-29. SROC summary receiver operator characteristic, CRC colorectal cancerBack to article page